Artemis Therapeutics Announces Two Recent Publications Highlighting Artemisone's Activity Against Human Cytomegalovirus And Malaria Jun 19, 2018 09:25AM
Data Presented At The 31st International Conference For Antiviral Research Demonstrate Artemis Therapeutics' Artemisone May Be An Effective Inhibitor Of Human CMV Replication Jun 12, 2018 09:25AM
New Data Demonstrate Artemis Therapeutics' Artemisone May Be An Effective Inhibitor Of Human CMV Replication Jun 7, 2018 09:25AM
Artemis Therapeutics Announces Additional Patent Issuance For Artemisone For The Treatment Of Viral Infections Apr 16, 2018 06:15AM
Artemis Therapeutics Announces Issuance Of European Patent For Artemisone For The Treatment Of Viral Infections Nov 28, 2017 06:25AM


Nov 6, 2017 08:00AM Artemis Therapeutics Receives Orphan Drug Designation From U.S. Food And Drug Administration For Artemisone For The Treatment Of Malaria
Oct 26, 2017 09:20AM Artemis Therapeutics Appoints Brian M. Culley As Chief Executive Officer